A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
暂无分享,去创建一个
Jan Verhaegen | Paul Rutgeerts | Kathleen Machiels | P. Rutgeerts | S. Vermeire | M. Ferrante | K. Verbeke | V. De Preter | J. Sabino | M. Joossens | V. Eeckhaut | F. Van Immerseel | J. Verhaegen | K. Machiels | I. Arijs | V. Ballet | Kristin Verbeke | Séverine Vermeire | Vicky De Preter | Ingrid Arijs | Marc Ferrante | Marie Joossens | Vera Ballet | João Sabino | Venessa Eeckhaut | Karolien Claes | Filip Van Immerseel | K. Claes
[1] C. Manichanh,et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease , 2006, Alimentary pharmacology & therapeutics.
[2] J. Bartlett,et al. The role of the intestinal microflora in experimental colitis. , 1977, The American journal of clinical nutrition.
[3] N. Borruel,et al. Unstable Composition of the Fecal Microbiota in Ulcerative Colitis During Clinical Remission , 2008, The American Journal of Gastroenterology.
[4] N. Pace,et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.
[5] Francisco Guarner,et al. Enteric Flora in Health and Disease , 2006, Digestion.
[6] F. Guarner,et al. Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission , 2013, Inflammatory bowel diseases.
[7] P. Langella,et al. Impact of the Metabolic Activity of Streptococcus thermophilus on the Colon Epithelium of Gnotobiotic Rats* , 2011, The Journal of Biological Chemistry.
[8] S. Tedelind,et al. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. , 2007, World journal of gastroenterology.
[9] P. Vandamme,et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives , 2011, Gut.
[10] Frans Schuit,et al. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway* , 2010, Inflammatory bowel diseases.
[11] E. Lindberg,et al. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. , 1988, Gut.
[12] C. Neut,et al. Self inflicted rectal ulcer: hearing is believing , 2003, Gut.
[13] P. Mortensen,et al. Faecal DL-lactate concentration in 100 gastrointestinal patients. , 1994, Scandinavian journal of gastroenterology.
[14] J. Doré,et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.
[15] R. Sartor,et al. Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.
[16] A. Merrill,et al. Ceramide-beta-D-glucuronide: synthesis, digestion, and suppression of early markers of colon carcinogenesis. , 1999, Cancer research.
[17] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[18] P. Mortensen,et al. Influence of intestinal inflammation (IBD) and small and large bowel length on fecal short-chain fatty acids and lactate , 1995, Digestive Diseases and Sciences.
[19] J. Swings,et al. Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. , 2004, FEMS microbiology ecology.
[20] C. Neut,et al. Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease , 1995, Digestive Diseases and Sciences.
[21] C. Manichanh,et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach , 2005, Gut.
[22] R. Caprilli,et al. Fecal lactate and ulcerative colitis. , 1988, Gastroenterology.
[23] Harry Sokol,et al. Analysis of bacterial bowel communities of IBD patients: What has it revealed? , 2008, Inflammatory bowel diseases.
[24] M. Naruszewicz,et al. Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[25] P. Rutgeerts,et al. Development of a screening method to determine the pattern of fermentation metabolites in faecal samples using on-line purge-and-trap gas chromatographic-mass spectrometric analysis. , 2006, Journal of chromatography. A.
[26] N. Saunders,et al. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate , 1989 .
[27] N. Barnich,et al. Role of bacteria in the etiopathogenesis of inflammatory bowel disease. , 2007, World journal of gastroenterology.
[28] Ateequr Rehman,et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. , 2011, Gastroenterology.
[29] J. Han,et al. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities , 1998, Archives of pharmacal research.
[30] J. Galmiche,et al. Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease. , 2000, Gut.
[31] S. Duncan,et al. Distribution of beta-glucosidase and beta-glucuronidase activity and of beta-glucuronidase gene gus in human colonic bacteria. , 2008, FEMS microbiology ecology.
[32] R. Sartor,et al. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases , 2009, Current opinion in infectious diseases.
[33] H. Flint,et al. Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. , 2006, International journal of systematic and evolutionary microbiology.
[34] Anders F. Andersson,et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.
[35] B. Fleischer,et al. Reactivity of infiltrating T lymphocytes with microbial antigens in Crohn's disease , 1991, The Lancet.
[36] S. Lynch,et al. Role of the microbiota in inflammatory bowel diseases. , 2012, Inflammatory bowel diseases.
[37] P. O’Toole,et al. Probiotic Bacteria Influence the Composition and Function of the Intestinal Microbiota , 2008, Interdisciplinary perspectives on infectious diseases.
[38] Julian Parkhill,et al. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease , 2011, BMC Microbiology.
[39] I. Forgacs,et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. , 1996, Gut.
[40] J. Doré,et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.
[41] J. Doré,et al. A metagenomic β-glucuronidase uncovers a core adaptive function of the human intestinal microbiome , 2010, Proceedings of the National Academy of Sciences.
[42] H. Flint,et al. Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut , 2000, Applied and Environmental Microbiology.
[43] S. Targan,et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. , 1995, The American journal of gastroenterology.
[44] Cecilia Jernberg,et al. Long-term impacts of antibiotic exposure on the human intestinal microbiota. , 2010, Microbiology.
[45] Mario Vaneechoutte,et al. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora , 2008, Inflammatory bowel diseases.
[46] J. Cummings,et al. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis , 2000, Gut.
[47] J. Garcia-Gil,et al. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction‐denaturing gradient gel electrophoresis , 2006, Inflammatory bowel diseases.
[48] B. Chassaing,et al. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. , 2011, Gastroenterology.
[49] P. Rutgeerts,et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum , 1991, The Lancet.
[50] E. Lindberg,et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. , 2003, Gastroenterology.
[51] P. Savelkoul,et al. The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics , 2001, Scandinavian journal of gastroenterology. Supplement.